LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)
Clinical trial NCT01041040 · COMPLETED
Trial details
- NCT number
- NCT01041040
- Sponsor
- PETHEMA Foundation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2012-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.